These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 30851244)

  • 1. A structural look at GABA
    Hernandez CC; Macdonald RL
    Brain Res; 2019 Jul; 1714():234-247. PubMed ID: 30851244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered inhibitory synapses in de novo GABRA5 and GABRA1 mutations associated with early onset epileptic encephalopathies.
    Hernandez CC; XiangWei W; Hu N; Shen D; Shen W; Lagrange AH; Zhang Y; Dai L; Ding C; Sun Z; Hu J; Zhu H; Jiang Y; Macdonald RL
    Brain; 2019 Jul; 142(7):1938-1954. PubMed ID: 31056671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deleterious Rare Variants Reveal Risk for Loss of GABAA Receptor Function in Patients with Genetic Epilepsy and in the General Population.
    Hernandez CC; Klassen TL; Jackson LG; Gurba K; Hu N; Noebels JL; Macdonald RL
    PLoS One; 2016; 11(9):e0162883. PubMed ID: 27622563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synaptic clustering differences due to different GABRB3 mutations cause variable epilepsy syndromes.
    Shi YW; Zhang Q; Cai K; Poliquin S; Shen W; Winters N; Yi YH; Wang J; Hu N; Macdonald RL; Liao WP; Kang JQ
    Brain; 2019 Oct; 142(10):3028-3044. PubMed ID: 31435640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in GABAA receptor subunits associated with genetic epilepsies.
    Macdonald RL; Kang JQ; Gallagher MJ
    J Physiol; 2010 Jun; 588(Pt 11):1861-9. PubMed ID: 20308251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo GABRG2 mutations associated with epileptic encephalopathies.
    Shen D; Hernandez CC; Shen W; Hu N; Poduri A; Shiedley B; Rotenberg A; Datta AN; Leiz S; Patzer S; Boor R; Ramsey K; Goldberg E; Helbig I; Ortiz-Gonzalez XR; Lemke JR; Marsh ED; Macdonald RL
    Brain; 2017 Jan; 140(1):49-67. PubMed ID: 27864268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo GABRA1 mutations in Ohtahara and West syndromes.
    Kodera H; Ohba C; Kato M; Maeda T; Araki K; Tajima D; Matsuo M; Hino-Fukuyo N; Kohashi K; Ishiyama A; Takeshita S; Motoi H; Kitamura T; Kikuchi A; Tsurusaki Y; Nakashima M; Miyake N; Sasaki M; Kure S; Haginoya K; Saitsu H; Matsumoto N
    Epilepsia; 2016 Apr; 57(4):566-73. PubMed ID: 26918889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rare variants in the GABA
    Markus F; Angelini C; Trimouille A; Rudolf G; Lesca G; Goizet C; Lasseaux E; Arveiler B; van Slegtenhorst M; Brooks AS; Abou Jamra R; Korenke GC; Neidhardt J; Owczarek-Lipska M
    Mol Genet Genomic Med; 2020 Sep; 8(9):e1388. PubMed ID: 32588540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectrum of GABAA receptor variants in epilepsy.
    Maljevic S; Møller RS; Reid CA; Pérez-Palma E; Lal D; May P; Lerche H
    Curr Opin Neurol; 2019 Apr; 32(2):183-190. PubMed ID: 30664068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gain-of-function variants in GABRD reveal a novel pathway for neurodevelopmental disorders and epilepsy.
    Ahring PK; Liao VWY; Gardella E; Johannesen KM; Krey I; Selmer KK; Stadheim BF; Davis H; Peinhardt C; Koko M; Coorg RK; Syrbe S; Bertsche A; Santiago-Sim T; Diemer T; Fenger CD; Platzer K; Eichler EE; Lerche H; Lemke JR; Chebib M; Møller RS
    Brain; 2022 May; 145(4):1299-1309. PubMed ID: 34633442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology of and therapeutic options for a GABRA1 variant linked to epileptic encephalopathy.
    Bai YF; Chiu M; Chan ES; Axerio-Cilies P; Lu J; Huh L; Connolly MB; Guella I; Farrer MJ; Xu ZD; Liu L; Demos M; Wang YT
    Mol Brain; 2019 Nov; 12(1):92. PubMed ID: 31707987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Pathogenic Basis for GABRG2 Mutations Associated With a Spectrum of Epilepsy Syndromes, From Generalized Absence Epilepsy to Dravet Syndrome.
    Kang JQ; Macdonald RL
    JAMA Neurol; 2016 Aug; 73(8):1009-16. PubMed ID: 27367160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural analysis of pathogenic missense mutations in GABRA2 and identification of a novel de novo variant in the desensitization gate.
    Sanchis-Juan A; Hasenahuer MA; Baker JA; McTague A; Barwick K; Kurian MA; Duarte ST; ; Carss KJ; Thornton J; Raymond FL
    Mol Genet Genomic Med; 2020 Jul; 8(7):e1106. PubMed ID: 32347641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo variants in GABRA2 and GABRA5 alter receptor function and contribute to early-onset epilepsy.
    Butler KM; Moody OA; Schuler E; Coryell J; Alexander JJ; Jenkins A; Escayg A
    Brain; 2018 Aug; 141(8):2392-2405. PubMed ID: 29961870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variable Expression of GABAA Receptor Subunit Gamma 2 Mutation in a Nuclear Family Displaying Developmental and Encephalopathic Phenotype.
    Nwosu G; Reddy SB; Riordan HRM; Kang JQ
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rare GABRA3 variants are associated with epileptic seizures, encephalopathy and dysmorphic features.
    Niturad CE; Lev D; Kalscheuer VM; Charzewska A; Schubert J; Lerman-Sagie T; Kroes HY; Oegema R; Traverso M; Specchio N; Lassota M; Chelly J; Bennett-Back O; Carmi N; Koffler-Brill T; Iacomino M; Trivisano M; Capovilla G; Striano P; Nawara M; Rzonca S; Fischer U; Bienek M; Jensen C; Hu H; Thiele H; Altmüller J; Krause R; May P; Becker F; ; Balling R; Biskup S; Haas SA; Nürnberg P; van Gassen KLI; Lerche H; Zara F; Maljevic S; Leshinsky-Silver E
    Brain; 2017 Nov; 140(11):2879-2894. PubMed ID: 29053855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic spectrum of GABRA1: From generalized epilepsies to severe epileptic encephalopathies.
    Johannesen K; Marini C; Pfeffer S; Møller RS; Dorn T; Niturad CE; Gardella E; Weber Y; Søndergård M; Hjalgrim H; Nikanorova M; Becker F; Larsen LH; Dahl HA; Maier O; Mei D; Biskup S; Klein KM; Reif PS; Rosenow F; Elias AF; Hudson C; Helbig KL; Schubert-Bast S; Scordo MR; Craiu D; Djémié T; Hoffman-Zacharska D; Caglayan H; Helbig I; Serratosa J; Striano P; De Jonghe P; Weckhuysen S; Suls A; Muru K; Talvik I; Talvik T; Muhle H; Borggraefe I; Rost I; Guerrini R; Lerche H; Lemke JR; Rubboli G; Maljevic S
    Neurology; 2016 Sep; 87(11):1140-51. PubMed ID: 27521439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel variant in GABRB2 associated with intellectual disability and epilepsy.
    Srivastava S; Cohen J; Pevsner J; Aradhya S; McKnight D; Butler E; Johnston M; Fatemi A
    Am J Med Genet A; 2014 Nov; 164A(11):2914-21. PubMed ID: 25124326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De novo and inherited mutations in the X-linked gene CLCN4 are associated with syndromic intellectual disability and behavior and seizure disorders in males and females.
    Palmer EE; Stuhlmann T; Weinert S; Haan E; Van Esch H; Holvoet M; Boyle J; Leffler M; Raynaud M; Moraine C; van Bokhoven H; Kleefstra T; Kahrizi K; Najmabadi H; Ropers HH; Delgado MR; Sirsi D; Golla S; Sommer A; Pietryga MP; Chung WK; Wynn J; Rohena L; Bernardo E; Hamlin D; Faux BM; Grange DK; Manwaring L; Tolmie J; Joss S; ; Cobben JM; Duijkers FAM; Goehringer JM; Challman TD; Hennig F; Fischer U; Grimme A; Suckow V; Musante L; Nicholl J; Shaw M; Lodh SP; Niu Z; Rosenfeld JA; Stankiewicz P; Jentsch TJ; Gecz J; Field M; Kalscheuer VM
    Mol Psychiatry; 2018 Feb; 23(2):222-230. PubMed ID: 27550844
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.